J. Canick

F. Malone, R. Ball, D. Nyberg, 2009, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

The maintenance of mitochondrial size in the rat adrenal cortex zona fasciculata by ACTH.

J. Canick, J. Purvis, 1972, Experimental and molecular pathology.

First-Trimester Septated Cystic Hygroma: Prevalence, Natural History, and Pediatric Outcome

F. Malone, R. Ball, D. Nyberg, 2005, Obstetrics and gynecology.

Maternal Prenatal Screening for Fetal Defects

J. Canick, A. R. Macrae, 2004 .

Cytochrome P-450 and the aromatization of 16α-hydroxytestosterone and androstenedione by human placental microsomes

J. Canick, K. Ryan, 1976, Molecular and Cellular Endocrinology.

Prenatal screening for trisomy 18 in the second trimester

R. Osathanondh, J. Canick, G. Palomaki, 1990, Prenatal diagnosis.

Maternal serum unconjugated oestriol as an antenatal screening test for Down's syndrome

J. Canick, H. Cuckle, J. Densem, 1988, British journal of obstetrics and gynaecology.

Low second trimester maternal serum unconjugated oestriol in pregnancies with Down's syndrome

J. Canick, N. Wald, H. Cuckle, 1988, British journal of obstetrics and gynaecology.

Control of cytochrome P-450 in rat testis mitochondria by human chorionic gonadotrophin.

J. Canick, J. H. Rosenbaum, J. Hologgitas, 1973, Archives of biochemistry and biophysics.

Lifetime of microsomal cytochrome P-450 and steroidogenic enzymes in rat testis as influenced by human chorionic gonadotrophin.

J. Canick, J. H. Rosenbaum, J. Hologgitas, 1973, Archives of biochemistry and biophysics.

High-affinity steroid binding to rat testis 17α-hydroxylase and human placental aromatase

R. Barbieri, J. Canick, K. Ryan, 1981 .

Danazol inhibits steroidogenesis in the rat testis in vitro.

R. Barbieri, J. Canick, K. Ryan, 1977, Endocrinology.

Danazol inhibits human adrenal 21-and 11 beta-hydroxylation in vitro.

R. Osathanondh, R. Barbieri, J. Canick, 1980, Steroids.

Estrogen 2-hydroxylase: Activity in rat tissues

R. Barbieri, J. Canick, K. Ryan, 1978, Steroids.

Comparison of 12 assays for detecting hCG and related molecules in urine samples from Down syndrome pregnancies

J. Canick, L. Cole, G. Palomaki, 1997, Prenatal diagnosis.

Collaborative study of maternal urine β ‐core human chorionic gonadotrophin screening for Down syndrome

J. Canick, H. Cuckle, L. Kellner, 1999, Prenatal diagnosis.

Urinary analyte screening: a noninvasive detection method for Down syndrome?

J. Canick, L. Cole, H. Cuckle, 1999, Molecular medicine today.

Detection of β-core fragment in second trimester Down's syndrome pregnancies

J. Canick, L. Cole, H. Cuckle, 1996 .

LETTER TO THE EDITOR. URINARY β‐CORE‐hCG SCREENING IN THE FIRST TRIMESTER

J. Canick, H. Cuckle, J. V. van Lith, 1996 .

First trimester screening for aneuploidy: serum biochemical markers.

J. Canick, L. Kellner, 1999, Seminars in perinatology.

Endocrine analytes in multiple-marker screening.

J. Canick, G. Lambert-Messerlian, 1998, Clinics in perinatology.

Second-Trimester Maternal Serum Markers in Twin Pregnancy With Complete Mole: Report of 2 Cases

J. Canick, G. Lambert-Messerlian, H. Pinar, 2005, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.

Prenatal screening for Down syndrome: current and future methods.

J. Canick, G. Lambert-Messerlian, D. Saller, 2003, Clinics in laboratory medicine.

First-trimester screening for aneuploidy: research or standard of care?

F. Malone, R. Berkowitz, M. D'Alton, 2000, American journal of obstetrics and gynecology.

Second‐trimester maternal serum analyte levels associated with fetal trisomy 13

J. Canick, J. Haddow, G. Palomaki, 1999, Prenatal diagnosis.

Multiple-marker screening in pregnancies with hydropic and nonhydropic Turner syndrome.

J. Canick, M. Blitzer, D. Saller, 1992, American journal of obstetrics and gynecology.

FIRST-TRIMESTER BIOCHEMICAL SCREENING FOR DOWN SYNDROME

J. Canick, N. Wald, H. Cuckle, 1988, The Lancet.

Clinical application of inhibin a measurement: prenatal serum screening for Down syndrome.

J. Canick, G. Lambert-Messerlian, 2004, Seminars in reproductive medicine.

Evaluation of cell-free fetal DNA as a second-trimester maternal serum marker of Down syndrome pregnancy.

J. Canick, G. Lambert-Messerlian, G. Palomaki, 2003, Clinical chemistry.

Molecular weight forms of inhibin A, inhibin B and pro‐αC in maternal serum, amniotic fluid and placental extracts of normal and Down syndrome pregnancies

J. Canick, G. Lambert-Messerlian, E. Wallace, 2002, Prenatal diagnosis.

Second trimester serum markers.

J. Canick, A. R. Macrae, 2005, Seminars in perinatology.

Progesterone, Inhibin, and hCG Multiple Marker Strategy to Differentiate Viable From Nonviable Pregnancies

J. Peipert, J. Canick, G. Lambert-Messerlian, 2000, Obstetrics and gynecology.

Second trimester amniotic fluid oestriol, dehydroepiandrosterone sulphate, and human chorionic gonadotrophin levels in Down's syndrome

J. Canick, H. Cuckle, J. Densem, 1991, British journal of obstetrics and gynaecology.

Second-Trimester Levels of Maternal Serum Human Chorionic Gonadotropin and Inhibin A as Predictors of Preeclampsia in the Third Trimester of Pregnancy

J. Canick, G. Lambert-Messerlian, F. Petraglia, 2000, The Journal of the Society for Gynecologic Investigation: JSGI.

Proteomic analysis of maternal serum in down syndrome: identification of novel protein biomarkers.

Mary E D'Alton, Surendra Dasari, F. Malone, 2007, Journal of proteome research.

Properties of the aromatase system associated with the mitochondrial fraction of human placenta

J. Canick, K. Ryan, 1978, Steroids.

The inhibition of 16α-hydroxytestosterone aromatization by carbon monoxide

J. Canick, K. Ryan, 1975 .

Prenatal screening for Down's syndrome with use of maternal serum markers.

J. Canick, J. Haddow, G. Knight, 1992, The New England journal of medicine.

High maternal serum inhibin A levels following the loss of one fetus in a twin pregnancy

J. Canick, G. Lambert-Messerlian, P. Sweeney, 2000, Prenatal diagnosis.

Maternal serum biochemical markers in pregnancies with fetal parvovirus B19 infection

J. Canick, D. Saller, B. Rogers, 1993, Prenatal diagnosis.

Androgen aromatization and 5 alpha-reduction in ferret brain during perinatal development: effects of sex and testosterone manipulation.

J. Canick, S. Tobet, M. J. Baum, 1985, Endocrinology.

Comparison of maternal serum total activin A and inhibin A in normal, preeclamptic, and nonproteinuric gestationally hypertensive pregnancies.

J. Canick, G. Lambert-Messerlian, J. Hogan, 1999, American journal of obstetrics and gynecology.

Variability in thyroid-stimulating hormone suppression by human chronic gonadotropin during early pregnancy (Journal of Clinical Endocrinology and Metabolism (2008) 93, (3341-3347))

F. Malone, D. Nyberg, M. D'Alton, 2008 .

Variability in thyroid-stimulating hormone suppression by human chorionic [corrected] gonadotropin during early pregnancy.

F. Malone, D. Nyberg, M. D'Alton, 2008, The Journal of clinical endocrinology and metabolism.

The effect of adrenocorticotrophin on protein degradation in rat adrenal gland and liver.

J. Canick, D. B. Villee, 1974, The Biochemical journal.

Maternal serum hCG levels in triploidy: Variability and need to consider molar tissue

J. Canick, C. E. Oyer, 1992, Prenatal diagnosis.

Maternal Thyroid Hypofunction and Pregnancy Outcome

F. Malone, M. D'Alton, L. Sullivan, 2008, Obstetrics and gynecology.

Location of enzymes of androgen and estrogen biosynthesis in the testis of the ground squirrel (Citellus lateralis).

J. Canick, G. Callard, J. Pudney, 1985, Biology of reproduction.

Second‐trimester maternal serum inhibin A levels in fetal trisomy 18 and Turner syndrome with and without hydrops

J. Canick, D. Saller, C. French, 1998, Prenatal diagnosis.

Estrogen synthesis by immature rat sertoli cells in vitro.

J. Canick, K. Ryan, M. Dym, 1983, Journal of andrology.

SECOND TRIMESTER SCREENING FOR TRISOMY 21

R. Osathanondh, J. Canick, J. Haddow, 1989, The Lancet.

Maternal serum cell-free fetal DNA levels are increased in cases of trisomy 13 but not trisomy 18

J. Canick, D. Bianchi, T. Wataganara, 2003, Human Genetics.

Down syndrome and cell-free fetal DNA in archived maternal serum.

J. Canick, D. Bianchi, A. Farina, 2002, American journal of obstetrics and gynecology.

Estrogen synthesis in Leydig cells: structural-functional correlations in Necturus testis.

J. Canick, G. Callard, J. Pudney, 1980, Biology of reproduction.

First‐ and second‐trimester Down syndrome screening markers in pregnancies achieved through assisted reproductive technologies (ART): a FASTER trial study

R. Ball, D. Nyberg, C. Comstock, 2006, Prenatal diagnosis.

Serum Triple‐Marker Screening in In Vitro Fertilization and Naturally Conceived Pregnancies

J. Canick, D. Saller, J. Hogan, 1997, Obstetrics and gynecology.

First‐ and second‐trimester Down syndrome screening markers in pregnancies achieved through assisted reproductive technologies (ART): a FASTER trial study

F. Malone, R. Ball, D. Nyberg, 2006, Prenatal diagnosis.

DNA sequencing of maternal plasma to identify Down syndrome and other trisomies in multiple gestations

Cosmin Deciu, J. Canick, G. Lambert-Messerlian, 2012, Prenatal diagnosis.

Noninvasive prenatal detection of sex chromosomal aneuploidies by sequencing circulating cell‐free DNA from maternal plasma

W. Meschino, J. Canick, G. Palomaki, 2013, Prenatal diagnosis.

High-Throughput Massively Parallel Sequencing for Fetal Aneuploidy Detection from Maternal Plasma

J. Canick, G. Palomaki, Ž. Džakula, 2013, PLoS ONE.

Feasibility of Using Plasma Rather Than Serum in First and Second Trimester Multiple Marker Down's Syndrome Screening

M. Phipps, J. Canick, G. Lambert-Messerlian, 2012, Journal of medical screening.

Prospective intervention trial of a screening protocol to identify fetal trisomy 18 using maternal serum alpha‐fetoprotein, unconjugated oestriol, and human chorionic gonadotropin

J. Canick, J. Haddow, G. Knight, 1992, Prenatal diagnosis.

Sequential first- and second-trimester TSH, free thyroxine, and thyroid antibody measurements in women with known hypothyroidism: a FaSTER trial study.

F. Malone, D. Nyberg, J. Canick, 2008, American journal of obstetrics and gynecology.

A summary analysis of Down syndrome markers in the late first trimester.

J. Canick, G. Lambert-Messerlian, G. Palomaki, 2007, Advances in clinical chemistry.

Very high inhibin A concentration attributed to heterophilic antibody interference.

J. Canick, G. Lambert-Messerlian, C. Bandera, 2007, Clinical chemistry.

Second trimester levels of maternal serum inhibin A in pregnancies affected by fetal neural tube defects

J. Canick, G. Lambert-Messerlian, G. Palomaki, 2000, Prenatal diagnosis.

Current state of second trimester screening for Down's syndrome

J. Canick, 1998, Journal of medical screening.

Maternal Serum Total Activin a in Pregnancies Affected with Fetal Down's Syndrome

J. Canick, G. Lambert-Messerlian, G. Palomaki, 1996, Journal of medical screening.

Second Trimester Levels of Maternal Serum Inhibi A, Total Inhibin, α Inhibin Precursor, and Activin in Down's Syndrome Pregnancy

J. Canick, G. Lambert-Messerlian, G. Palomaki, 1996, Journal of medical screening.

Comparison of Serum Markers in First-Trimester Down Syndrome Screening

F. Malone, R. Ball, D. Nyberg, 2006, Obstetrics and gynecology.

First and second trimester evaluation of risk (FASTER) trial: The role of second trimester genetic sonography

F. Malone, R. Ball, D. Nyberg, 2004 .

A high-sensitivity assay for amniotic fluid insulin at 14-20 weeks' gestation.

J. Canick, M. Carpenter, C. Shellum, 1999, Obstetrics and gynecology.

Thyroperoxidase and Thyroglobulin Antibodies in Early Pregnancy and Placental Abruption

F. Malone, D. Nyberg, J. Canick, 2011, Obstetrics and gynecology.

Examination of the pregnancy-associated plasma protein-A assay on the Beckman Coulter Access® platform: suitability for use in first trimester Down's syndrome screening

J. Canick, G. Lambert-Messerlian, G. Palomaki, 2010, Journal of medical screening.

Low maternal serum unconjugated estriol during prenatal screening as an indication of placental steroid sulfatase deficiency and X-linked ichthyosis.

J. Canick, D. Keren, R. Hackett, 1995, American journal of clinical pathology.

platform: suitability for use in first trimester Down's syndrome screening ® Examination of the pregnancy-associated plasma protein-A assay on the Beckman Coulter Access

J. Canick, G. Lambert-Messerlian, G. Palomaki, 2013 .

Second-Trimester Maternal Serum Alpha- Fetoprotein, Unconjugated Estriol, and hCG Levels in Pregnancies With Ventral Wall Defects

J. Canick, J. Haddow, G. Knight, 1994, Obstetrics and Gynecology.

Aromatization of norethindrone to ethinyl estradiol by human placental microsomes.

R. Barbieri, J. Canick, K. Ryan, 1983, Journal of Clinical Endocrinology and Metabolism.

Impact of adjusting for the reciprocal relationship between maternal weight and free thyroxine during early pregnancy.

F. Malone, J. Canick, G. Lambert-Messerlian, 2013, Thyroid : official journal of the American Thyroid Association.

Early onset preeclampsia and second trimester serum markers

J. Canick, G. Lambert-Messerlian, G. Palomaki, 2009, Prenatal diagnosis.

Second‐trimester levels of maternal serum unconjugated oestriol and human chorionic gonadotropin in pregnancies affected by fetal anencephaly and open spina bifida

J. Canick, J. Haddow, G. Knight, 1990, Prenatal diagnosis.

Maternal serum unconjugated estriol levels are lower in the presence of fetal Down syndrome.

J. Canick, N. Wald, H. Cuckle, 1990, American journal of obstetrics and gynecology.

Normal differentiation of masculine sexual behavior in male ferrets despite neonatal inhibition of brain aromatase or 5-alpha-reductase activity.

C. A. Gallagher, J. Canick, M. J. Baum, 1983, Neuroendocrinology.

Second-trimester levels of maternal serum human chorionic gonadotropin and inhibin a as predictors of preeclampsia in the third trimester of pregnancy.

J. Canick, G. Lambert-Messerlian, F. Petraglia, 2000 .

The effect of ovulation induction on the concentration of maternal serum relaxin in twin pregnancies.

J. Canick, L. Goldsmith, G. Weiss, 1996, American journal of obstetrics and gynecology.

Subclinical hypothyroidism and pregnancy outcomes

F. Malone, L. Sullivan, J. Canick, 2005 .

Maternal serum marker levels in two pregnancies affected with Smith‐Lemli‐Opitz syndrome

J. Canick, L. Bradley, Jacob A. Canick, 1997, Prenatal diagnosis.

Methodology for the Study of Metabolism: Analyses of Proteins, Peptides, and Small Molecules

J. Canick, 1998 .

Maternal serum screening for aneuploid pregnancy by alphafetoprotein, hCG, and unconjugated estriol

J. Canick, W. Miller, P. Heyl, 1990, Obstetrics and gynecology.

Concentrations of Serum Total Activin A and Inhibin A in Preterm and Term Labor Patients: A Cross-Sectional Study

J. Canick, A. Farina, N. Groome, 2003, The Journal of the Society for Gynecologic Investigation: JSGI.

Estrone sulfatase activity in the human brain and estrone sulfate levels in the normal menstrual cycle.

J. Canick, K. Elkind-Hirsch, D. Tulchinsky, 1984, Journal of steroid biochemistry.

Studies on the role of catecholamines in the regulation of the developmental pattern of hypothalamic aromatase

J. Canick, S. Tobet, S. Leeman, 1987, Steroids.

Aromatase activity in the perinatal rat forebrain: effects of age, sex and intrauterine position.

J. Canick, S. Tobet, M. J. Baum, 1985, Brain research.

Levels of urinary beta‐core fragment, total oestriol, and the ratio of the two in second‐trimester screening for Down syndrome

R. Osathanondh, J. Canick, G. Palomaki, 1997, Prenatal diagnosis.

Maternal serum analyte levels in pregnancies with fetal Down syndrome resulting from translocations.

J. Canick, D. Saller, R. Mooney, 1997, American journal of obstetrics and gynecology.

Second‐trimester maternal serum progesterone levels in Turner syndrome with and without hydrops and in trisomy 18

J. Canick, C. French, C. J. Peterson, 1999, Prenatal diagnosis.

Increased concentrations of prostate-specific antigen in maternal serum from pregnancies affected by fetal Down syndrome.

E. Diamandis, J. Canick, G. Lambert-Messerlian, 1998, Clinical chemistry.

Midpregnancy serum C-peptide concentration and subsequent pregnancy-induced hypertension.

J. Canick, M. Carpenter, J. Hogan, 2001, Diabetes care.

Maternal serum screening for fetal Down syndrome: the detection of other pathologies.

J. Canick, D. Saller, 1996, Clinical obstetrics and gynecology.

A normative study of obstetric complications associated with fetal trisomy 18.

J. Canick, D. Saller, J. Star, 1996, Journal of Perinatology.

Placental sulfatase deficiency: a case study.

R. Osathanondh, J. Canick, K. Ryan, 1976, The Journal of clinical endocrinology and metabolism.

Safety First: Choices in Antenatal Screening for Down's Syndrome

J. Canick, 2003 .

Mechanism of Increased Maternal Serum Total Activin A and Inhibin A in Preeclampsia

J. Canick, F. Petraglia, F. Reis, 2002, The Journal of the Society for Gynecologic Investigation: JSGI.

Maternal serum screening for fetal Down syndrome: clinical aspects.

J. Canick, D. Saller, 1996, Clinical obstetrics and gynecology.

Serum screening for Down's syndrome: Authors' reply

J. Canick, N. Wald, H. Cuckle, 1989 .

Seeking other disorders within antenatal serum screening programmes for Down's syndrome

J. Canick, N. Wald, 2002, Journal of medical screening.

Serum inhibin levels are lower in ectopic than intrauterine spontaneously conceived pregnancies.

J. Canick, G. Lambert-Messerlian, D. Seifer, 1996, Fertility and sterility.

The aromatization of androgens by primary monolayer cultures of fetal rat hypothalamus.

J. Canick, S. Leeman, K. Ryan, 1977, Endocrinology.

First Trimester Bleeding and Pregnancy Outcome in Gravidas with Normal and Low Folate Levels

J. Canick, S. Contag, R. Neiger, 1993, American journal of perinatology.

Effect of folic acid fortification on prevalence of neural tube defects in Rhode Island

J. Canick, G. Lambert-Messerlian, G. Palomaki, 2004, Journal of medical screening.

Detection of down syndrome by proteomic profiling of maternal serum

F. Malone, J. Canick, G. Lambert-Messerlian, 2004 .

Second‐trimester maternal serum analyte levels associated with fetal trisomy 13

J. Canick, J. Haddow, G. Palomaki, 1999, Prenatal diagnosis.

Fetal neural tube defects: maternal serum and amniotic fluid activin A levels

J. Canick, G. Lambert-Messerlian, G. Buonocore, 2004, Prenatal diagnosis.

First-trimester or second-trimester screening, or both, for Down's syndrome.

A. Rudnicka, F. Malone, R. Ball, 2005, The New England journal of medicine.

22 Fetal down syndrome is associated with increased cell-free fetal DNA levels in archived maternal serum samples

J. Canick, D. Bianchi, M. Carpenter, 2001 .

Urinary beta-core-hCG screening in the first trimester.

J. Canick, H. Cuckle, J. V. van Lith, 1996, Prenatal diagnosis.

First-Trimester Septated Cystic Hygroma: Prevalence, Natural History, and Pediatric Outcome

F. Malone, R. Ball, D. Nyberg, 2005, Obstetrics and gynecology.

Second‐trimester maternal serum progesterone levels in Turner syndrome with and without hydrops and in trisomy 18

J. Canick, G. Lambert-Messerlian, D. Saller, 1999, Prenatal diagnosis.

Second‐trimester maternal serum inhibin A levels in fetal trisomy 18 and Turner syndrome with and without hydrops

J. Canick, G. Lambert-Messerlian, D. Saller, 1998, Prenatal diagnosis.

Quality assessment of routine nuchal translucency measurements: a North American laboratory

J. Canick, G. Lambert-Messerlian, L. Neveux, 2008 .

Impact of smoking on maternal serum markers and prenatal screening in the first and second trimesters

J. Canick, G. Lambert-Messerlian, G. Palomaki, 2011, Prenatal diagnosis.